Alternatively, if combined inhibition of the degradation of several Skp2 targets is required, inhibitors of the Skp1/Skp2 interaction or inhibitors of Skp2 expression may be effective against pulmonary fibrosis. Here, SKP1 is linked to pulmonary fibrosis.